Trial Profile
Phase II Study Of Iodine-131 Anti-B1 Antibody Plus CHOP For Patients With Previously Untreated Mantle Cell Lymphoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Iodine-131 tositumomab (Primary) ; Tositumomab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 20 Oct 2009 New trial record